drugset / Trial / NCT01244633
Ecopipam Treatment of Tourette Syndrome
NaSingle-groupOpen-labelTreatment
Summary
Tourette's Syndrome is a neurological disease characterized by verbal and motor tics. The currently available drug treatments are considered to be inadequate. This clinical trial is designed to test if ecopipam is effective for the treatment of Tourette's Syndrome in adults.
Timeline
- Start
- 2010-10
- Primary completion
- 2012-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ecopipam | Small molecule | 50 mg | — |
| Subject | Ecopipam | Small molecule | 100 mg | — |